Purpurins and benzochlorins as sensitizers for photodynamic therapy

Journal of Photochemistry and Photobiology B: Biology

Volumn 34, Issue 2-3, 1996, Pages 109-116

  Garbo, Greta M ^a,b  

^a UNIVERSITY OF TOLEDO   (United States)

^b GMG Consulting   (United States)

Author keywords

Benzochlorin; Fluorescence; Photodynamic therapy; Photosensitizers; Purpurins

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; ETIOPURPURIN; PHOTOFRIN; PHOTOSENSITIZING AGENT; PURPURIN;

ARTICLE; CANCER; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG STRUCTURE; FLUORESCENCE; HUMAN; KAPOSI SARCOMA; LEUKEMIA CELL; NONHUMAN; PHOTOCHEMISTRY; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; SKIN CANCER;

EID: 0030199792     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/1011-1344(96)07343-5     Document Type: Article

References (64)

1. [1] T.J. Dougherty, Photodynamic therapy, Photochem. Photobiol., 58 (1993) 895-900.
2. [2] J. Levy, The preclinical and clinical development of Photofrin® and benzoporphyrin derivative: a reflection on opportunities and changes, J. Photochem. Photobiol. B: Biol., 30 (1995) 79-82 (ESP Newsletter).
3. [3] J. Levy, A. Chan and H.A. Strong, The clinical status of benzoporphyrin derivative, Proc. SPIE, 2625 (1995) 86-95.
4. [4] PDT Inc., News Release, December 11, 1995.
5. 6 for the treatment of cutaneous diseases, Photochem. Photobiol., 61S (1995) 518 (Abstract).
6. [6] H.B. Ris, H.J. Altermatt and R. Inderbitzi et al., Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results, Br. J. Cancer, 64 (1991) 1116-1120.
7. [7] A.M. Ronn, L.A. Lofgren and Westerborn, Interspecies pharmacokinetics as applied to the "hard drug" photosensitizing agent meta(tetrahydroxylchlorin), Proc. SPIE, 2625 (1995) 118-123.
8. [8] J.C. Kennedy, R.H. Pottier and D.C. Pross, Photodynamic therapy with endogeneous protoporphyrin IX: basic principles and present clinical experience, J. Photochem. Photobiol. B: Biol., 6 (1990) 143-148.
9. [9] S.L. Marcus, A.L. Golub and D.G. Shulman, Photodynamic therapy (PDT) using topical and systemic 5-aminolevulinic acid (ALA) for photosensitization (ALA-PDT): current clinical status, Photochem. Photobiol., 61S (1995) TAM-C3 (Abstract).
10. [10] A.R. Morgan and N.C. Tertel, Observations on the synthesis and spectroscopic characteristics of purpurins, J. Org. Chem., 51 (1986) 1347-1350.
11. [11] R.B. Woodward, Total synthese des chlorophylls, Angew Chem., 72 (1960) 651-751.
12. [12] D. Kessel, Determinants of photosensitization by purpurins, Photochem. Photobiol., 50 (1989) 169-174.
13. [13] P. Sekher and G.M. Garbo, Spectroscopic studies of tin ethyl etiopurpurin in homogeneous and heterogeneous systems, J. Photochem. Photobiol. B: Biol., 20 (1993) 117-125.
14. [14] D. Kessel and A.R. Morgan, Photosensitization with etiobenzochlorins and octaethylbenzochlorins, Photochem. Photobiol., 58 (1993) 521-526.
15. [15] D.P. Arnold, R. Gaete-Holmes, A.W. Johnson, A.R.P. Smith and G.A. Williams, Wittig condensation products from nickel meso-formyloctaethylporphyrin and meso-formyletioporphyrin-I and some cyclization reactions, J. Chem. Soc., Perkin Trans. 1 (1978) 1660-1670.
16. [16] A.R. Morgan, G.M. Garbo, A. Rampersaud, D. Skalkos, R.W. Keck and S.H. Selman, Photodynamic action of benzochlorins, SPIE Conf. Proc., 1065 (1989) 146-151.
17. [17] A.R. Morgan, D. Skalkos, G. Maguire, A. Rampersaud, G.M. Garbo, R.W. Keck and S.H. Selman, Observations on the synthesis and in vivo photodynamic activity of some benzochlorins, Photochem. Photobiol., 55 (1991) 133-136.
18. [18] D. Skalkos and J.A. Hampton, Iminium salt benzochlorins as potential photosensitizers in photodynamic therapy, Med. Chem. Res., 2 (1992) 276-281.
19. [19] A.R. Morgan and S. Gupta, Synthesis of benzochlorin iminium salts with improved photosensitizing properties, Tetrahedron Lett., 35 (1994) 5347-5352.
20. [20] D. Skalkos, J.A. Hampton, R.W. Keck, M. Wagoner and S.H. Selman, Iminium salt benzochlorin: structure-activity relationship studies, Photochem. Photobiol., 59 (1994) 175-181.
21. [21] C.F. Borland, D. McGarvey, T.G. Truscott and A.R. Morgan, Laser flash photolysis of purpurins: novel potential photosensitizers of interest for photodynamic therapy of cancer, J. Photochem. Photobiol. B: Biol., 2 (1988) 427-434.
22. [22] A.N. Macpherson, D. Kessel, A.R. Morgan, I. Munro and T.G. Truscott, A photophysical study of some purpurins, J. Chem. Soc., Faraday Trans., 86 (1990) 3081-3085.
23. [23] A.R. Morgan, G.M. Garbo and T.G. Truscott, Photophysical and photochemical properties of purpurins, SPIE Conf. Proc., 997 (1988) 139-144.
24. [24] D. Kessel, A.R. Morgan and G.M. Garbo, Sites and efficacy of photodamage by tin etiopurpurin in vitro using different delivery systems, Photochem. Photobiol., 54 (1991) 193-196.
25. [25] D. Kessel, Sites of photodamage by the iminium salt of a copper octaethylbenzochlorin, Photochem. Photobiol., 58 (1993) 623-626.
26. [26] D. Kessel, Use of fluorescent probes for characterizing sites of photodamage, The Spectrum, 6 (2) (1993) 1-6.
27. [27] A.R. Morgan, L.S. Cheng, D. Skalkos and G.M. Garbo, Tin etiopurpurin dichloride-sensitized lipid photo-oxidation of erythrocyte membranes, Photochem. Photobiol., 52 (1990) 987-991.
28. [28] J.A. Hampton, D. Skalkos, P.M. Taylor and S.H. Selman, Iminium salt of copper benzochlorin (CDS1), a novel photosensitizer for photodynamic therapy: mechanism of cell killing, Photochem. Photobiol., 58 (1993) 100-105.
29. [29] D. Kessel, K. Woodburn and D. Skalkos, Impaired accumulation of a cationic photosensitizing agent by a cell line exhibiting multidrug resistance, Photochem. Photobiol., 60 (1994) 61-63.
30. [30] J.A. Hampton, D. Decker and D. Kessel, Immunohistochemical demonstration of multidrug resistance in the FANFT-induced urothelial tumor: implications for CDS1 mediated photodamage, Photochem. Photobiol., 59S (1994) 11S (Abstract).
31. [31] A.R. Morgan, G.M. Garbo, M. Kreimer-Birnbaum, R.W. Keck, K. Chaudhuri and S.H. Selman, Morphologic studies of the combined effect of purpurin derivatives and light on transplanted bladder tumors, Cancer Res., 47 (1987) 496-499.
32. [32] S.H. Selman, G.M. Garbo, R.W. Keck, K. Chaudhuri and A.R. Morgan A dose response analysis of purpurin derivatives used as photosensitizers for the photodynamic treatment of transplantable FANFT induced urothelial tumors, J. Urol., 137 (1987) 1255-1257.
33. [33] A.R. Morgan, G.M. Garbo, R.W. Keck and S.H. Selman, New photosensitizers for photodynamic therapy: combined effect of metallopurpurin derivatives and light on transplantable bladder tumors, Cancer Res., 48 (1988) 194-198.
34. [34] A.R. Morgan, M. Kreimer-Birnbaum, G.M. Garbo, R.W. Keck and S.H. Selman, Purpurins: improved photosensitizers for photodynamic therapy, SPIE Conf. Proc., 847 (1988) 29-35.
35. [35] A.R. Morgan and S.H. Selman, New photosensitizers for photodynamic therapy of tumors, Drugs of the Future, 12 (1988) 1073-1082.
36. [36] A.R. Morgan and G.M. Garbo, Biomedical application of porphyrin photosensitizes, Trends Photochem. Photobiol., 2 (1991) 229-236.
37. [37] S.H. Selman, J. Hampton, A.R. Morgan, R.W. Keck, A. Balkany and D. Skalkos, Copper benzochlorin, a novel photosensitizer for photodynamic therapy. Effects on a transplantable urothelial tumor, Photochem. Photobiol., 57 (1993) 681-685.
38. [38] A.R. Morgan, A. Rampersaud, G.M. Garbo, R.W. Keck and S.H. Selman, New sensitizers for photodynamic therapy: controlled synthesis of purpurins and their effects on normal tissue, J. Med. Chem., 32 (1989) 904-908.
39. [39] M.J. Maniak, P.D. Smith, F.S.I. Harrington, S.M. Steinberg, E. Glatstein and A. Russo, Protection against dihematoporphyrin ether photosensitivity, Photochem. Photobiol., 47 (1988) 823-830.
40. [40] A.R. Morgan, G.M. Garbo, R.W. Keck, L.D. Eriksen and S.H. Selman, Metallopurpurins and light: effect on transplantable rat bladder tumors and murine skin, Photochem. Photobiol., 51 (1990) 589-592.
41. [41] A.R. Morgan, G.M. Garbo, T. Krivak, M. Mastroianni, N. Petousis, T. St. Clair, M. Wiesenberger and I.E. van Lier, New sensitizers for PDT, Proc. SPIE, 1426 (1991) 350-355.
42. 2) in the tumor-bearing rat, Photochem. Photobiol., 57 (1993) 298-301.
43. 2 and light on transplantable FANFT induced bladder tumor, J. Urol., 143 (1990) 630-633.
44. [44] V.H. Fingar, T.J. Wieman, S.A. Wiele and K.A. Siegel, Effect of PDT using tin etiopurpurin on tissue microvasculature, Photochem. Photobiol., 55 (1992) 55S (Abstract).
45. [45] V.H. Fingar, T.J. Wieman and K. Weber Doak, Role of thromboxane and prostacyclin release on photodynamic therapy-induced destruction, Cancer Res., 50 (1990) 2599-2603.
46. [46] V.H. Fingar, K.A. Siegel, T.J. Wieman and K. Weber Doak, The effects of thromboxane inhibitors on the microvascular and tumor response to photodynamic therapy, Photochem. Photobiol., 58 (1993) 393-399.
47. [47] D.P. He, J.A. Hampton, R. Keck and S.H. Selman, Photodynamic therapy: effect on the endothelial cell of the rat aorta, Photochem. Photobiol., 54 (1991) 801-804.
48. 2, Proc. SPIE, 203 (1990) 118-125.
49. [49] D. Gal, P.C. McDonald, J.C. Porter and E.R. Simpson, Cholesterol metabolism in cancer cells in monolayer culture II. Low density lipoprotein metabolism, Int. J. Cancer, 28 (1981) 315-319.
50. [50] S. Vitolis, B. Angelin, S. Erickson, G. Gahrton, G. Juliusson, M. Masquelier, C. Paul, C. Peterson, C. Rudling, K. Söderbery-Reid and U. Tidefelt, Uptake of low density lipoproteins by human leukemia cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapy, Proc. Natl. Acad. Sci. USA, 87 (1990) 2598-2602.
51. [51] M.C. Luna, A. Ferrario, N. Rucker and C.J. Gomer, Decreased expression and function of α-2 macroglobulin receptor/low density lipoprotein receptor-related protein in photodynamic therapy-resistant mouse tumor cells. Cancer Res., 55 (1995) 1820-1823.
52. [52] A. Barel, G. Jori, A. Peron, P. Romandini, A. Pagnan and S. Biffanti, Role of high-, low-, and very low-idensity lipoproteins in the transport and tumor delivery of hematoporphyrin in vivo, Cancer Lett., 32 (1986) 145-150.
53. [53] C. Candide, J.C. Maziere, S. Goldstein, R. Santus, L. Dubertret, J.P. Reyftmann and J. Polonovsky, In vitro interaction of the photoactive porphyrin derivative Photofrin® II with low density lipoprotein, and its delivery to cultured human fibroblasts, FEBS Lett., 207 (1986) 133-138.
54. [54] D. Kessel, Porphyrin-lipoprotein association as a factor in porphyrin localization, Cancer Lett., 33 (1986) 183-188.
55. [55] L. Polo, E. Reddi, G. M. Garbo, A.R. Morgan and G. Jori, The distribution of the tumour photosensitizers Zn(II) -phthalocyanine and Sn(IV)-etiopurpurin among rabbit plasma proteins, Cancer Lett., 66 (1992) 217-223.
56. [56] M. Kongshaug, J. Moan, L.S. Cheng, G.M. Garbo, S. Kolbe, A.R. Morgan and C. Rimington, Binding of drugs to human plasma proteins, exemplified by Sn (IV)-etiopurpurin dichloride delivered in Cremophor and DMSO, Int. J. Biochem., 25 (1993) 739-760.
57. [57] M. Kongshaug, L.S. Cheng, J. Moan and C. Rimington, Interactions of Cremophor El with human plasma, Int. J. Biochem., 23 (1991) 473-478.
58. [58] K. Woodburn and D. Kessel, The alteration of plasma lipoprotein by Cremophor El, J. Photochem. Photobiol. B: Biol., 22 (1994) 197-201.
59. [59] M. Soncin, L. Polo, E. Reddi, G. Jori, M.E. Kenney, G. Cheng and M.A.J. Rodgers, Effect of delivery system on the distribution of Ge(IV)-octabutoxy-phthalocyanine in tumor bearing mice, Cancer Lett., 89 (1995) 101-106.
60. [60] J.B. Glen, S.C. Hunter and D.S. Thomson, The role of Cremophor El anaphylactoid reactions to i.v. anesthetics, Br. J. Anaesth., 54 (1982) 231P-232P.
61. [61] G. Thiel, M. Hermle and F.P. Brunner, Acutely impaired renal function during intravenous administration of cyclosporine A: a cremophore side effect, Clin. Nephrol., 25 (1986) S40-S42.
62. 2), presented at BIOS Europe 1995, Barcelona, September 1995, Abstract No. 2625-104.
63. 2): phase I/II clinical results for the treatment of cutaneous carcinomas, presented at the Sixth Meeting of the International Photodynamic Association, Melbourne, March 1996, Abstract.
64. 2) : phase I/II clinical results for the treatment of Aids-related cutaneous Kaposi's sarcoma, presented at the Sixth Meeting of the International Photodynamic Association, Melbourne, March 1996, Abstract.